
Robert E. Mosser
Examiner (ID: 16617, Phone: (571)272-4451 , Office: P/3714 )
| Most Active Art Unit | 3715 |
| Art Unit(s) | 3714, 3715, 3713, 3712 |
| Total Applications | 839 |
| Issued Applications | 347 |
| Pending Applications | 141 |
| Abandoned Applications | 372 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14057767
[patent_doc_number] => 10233167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-19
[patent_title] => 14-hydroxy-docosahexaenoic acid compounds
[patent_app_type] => utility
[patent_app_number] => 15/437211
[patent_app_country] => US
[patent_app_date] => 2017-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 21415
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 460
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15437211
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/437211 | 14-hydroxy-docosahexaenoic acid compounds | Feb 19, 2017 | Issued |
Array
(
[id] => 14005407
[patent_doc_number] => 10221139
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-05
[patent_title] => Inhibitors of histone demethylases
[patent_app_type] => utility
[patent_app_number] => 15/436055
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24793
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 636
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15436055
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/436055 | Inhibitors of histone demethylases | Feb 16, 2017 | Issued |
Array
(
[id] => 13645689
[patent_doc_number] => 09849143
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-26
[patent_title] => Broad spectrum antiviral and methods of use
[patent_app_type] => utility
[patent_app_number] => 15/434682
[patent_app_country] => US
[patent_app_date] => 2017-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13871
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15434682
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/434682 | Broad spectrum antiviral and methods of use | Feb 15, 2017 | Issued |
Array
(
[id] => 11662476
[patent_doc_number] => 20170151182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'TREATMENT OF SCHIZOPHRENIA USING BETA-CARYOPHYLLENE AND CB2 RECEPTOR AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 15/432198
[patent_app_country] => US
[patent_app_date] => 2017-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 10343
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15432198
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/432198 | TREATMENT OF SCHIZOPHRENIA USING BETA-CARYOPHYLLENE AND CB2 RECEPTOR AGONISTS | Feb 13, 2017 | Abandoned |
Array
(
[id] => 14005423
[patent_doc_number] => 10221147
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-05
[patent_title] => Heterocyclic compounds with working memory enhancing activity
[patent_app_type] => utility
[patent_app_number] => 15/429961
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13635
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15429961
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/429961 | Heterocyclic compounds with working memory enhancing activity | Feb 9, 2017 | Issued |
Array
(
[id] => 11820512
[patent_doc_number] => 20170209450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'MEK INHIBITORS IN THE TREATMENT OF VIRUS DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/428693
[patent_app_country] => US
[patent_app_date] => 2017-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 11746
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15428693
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/428693 | MEK INHIBITORS IN THE TREATMENT OF VIRUS DISEASES | Feb 8, 2017 | Abandoned |
Array
(
[id] => 12165285
[patent_doc_number] => 09884044
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-06
[patent_title] => 'Treatment using dantrolene'
[patent_app_type] => utility
[patent_app_number] => 15/406237
[patent_app_country] => US
[patent_app_date] => 2017-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16510
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15406237
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/406237 | Treatment using dantrolene | Jan 12, 2017 | Issued |
Array
(
[id] => 12302511
[patent_doc_number] => 09937191
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-10
[patent_title] => Inhibition of HIV infection through chemoprophylaxis
[patent_app_type] => utility
[patent_app_number] => 15/406344
[patent_app_country] => US
[patent_app_date] => 2017-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5894
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15406344
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/406344 | Inhibition of HIV infection through chemoprophylaxis | Jan 12, 2017 | Issued |
Array
(
[id] => 12177355
[patent_doc_number] => 20180036292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 15/550772
[patent_app_country] => US
[patent_app_date] => 2017-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4620
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550772
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550772 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS | Jan 11, 2017 | Abandoned |
Array
(
[id] => 12975559
[patent_doc_number] => 20170340603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => COMPOSITIONS AND METHODS FOR SKIN CARE
[patent_app_type] => utility
[patent_app_number] => 15/400510
[patent_app_country] => US
[patent_app_date] => 2017-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15400510
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/400510 | Compositions and methods for skin care | Jan 5, 2017 | Issued |
Array
(
[id] => 12059056
[patent_doc_number] => 20170335400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CANCERS'
[patent_app_type] => utility
[patent_app_number] => 15/395664
[patent_app_country] => US
[patent_app_date] => 2016-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 30013
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15395664
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/395664 | COMPOSITIONS AND METHODS FOR TREATING CANCERS | Dec 29, 2016 | Abandoned |
Array
(
[id] => 11567361
[patent_doc_number] => 20170106005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'TREATING CONDITIONS ASSOCIATED WITH INCREASED EOTAXIN WITH 25-HYDROXYVITAMIN D3'
[patent_app_type] => utility
[patent_app_number] => 15/393160
[patent_app_country] => US
[patent_app_date] => 2016-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5363
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15393160
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/393160 | Treating conditions associated with increased eotaxin with 25-hydroxyvitamin D3 | Dec 27, 2016 | Issued |
Array
(
[id] => 17798988
[patent_doc_number] => 11413254
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Application for (2R, 4R)-1,2,4-trihydroxyheptadec-16-yne in preparation of pharmaceutical composition for preventing or treating hepatic injury
[patent_app_type] => utility
[patent_app_number] => 16/471576
[patent_app_country] => US
[patent_app_date] => 2016-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4411
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471576
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/471576 | Application for (2R, 4R)-1,2,4-trihydroxyheptadec-16-yne in preparation of pharmaceutical composition for preventing or treating hepatic injury | Dec 21, 2016 | Issued |
Array
(
[id] => 11977439
[patent_doc_number] => 20170281593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'Methods of Treating Fatty Liver Disease'
[patent_app_type] => utility
[patent_app_number] => 15/383602
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10182
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15383602
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/383602 | Methods of Treating Fatty Liver Disease | Dec 18, 2016 | Abandoned |
Array
(
[id] => 15466103
[patent_doc_number] => 10548905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-04
[patent_title] => Amorphous onapristone compositions and methods of making the same
[patent_app_type] => utility
[patent_app_number] => 15/378004
[patent_app_country] => US
[patent_app_date] => 2016-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 8035
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15378004
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/378004 | Amorphous onapristone compositions and methods of making the same | Dec 12, 2016 | Issued |
Array
(
[id] => 16655959
[patent_doc_number] => 20210052595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => INHIBITORS OF EZH2 AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/060164
[patent_app_country] => US
[patent_app_date] => 2016-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24702
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060164
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/060164 | INHIBITORS OF EZH2 AND METHODS OF USE THEREOF | Dec 6, 2016 | Abandoned |
Array
(
[id] => 11512909
[patent_doc_number] => 20170079982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'ANTIVIRAL THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/366442
[patent_app_country] => US
[patent_app_date] => 2016-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5966
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15366442
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/366442 | Antiviral therapy | Nov 30, 2016 | Issued |
Array
(
[id] => 11602477
[patent_doc_number] => 20170119777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'ANTIVIRAL THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/366566
[patent_app_country] => US
[patent_app_date] => 2016-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5963
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15366566
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/366566 | ANTIVIRAL THERAPY | Nov 30, 2016 | Abandoned |
Array
(
[id] => 11491359
[patent_doc_number] => 20170065540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-09
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING INFECTION'
[patent_app_type] => utility
[patent_app_number] => 15/356940
[patent_app_country] => US
[patent_app_date] => 2016-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 61865
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15356940
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/356940 | Methods and compositions for treating infection | Nov 20, 2016 | Issued |
Array
(
[id] => 16320229
[patent_doc_number] => 10780176
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-22
[patent_title] => Methods for improved protection and delivery of aminothiols and analogs thereof
[patent_app_type] => utility
[patent_app_number] => 15/776674
[patent_app_country] => US
[patent_app_date] => 2016-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 15
[patent_no_of_words] => 25170
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15776674
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/776674 | Methods for improved protection and delivery of aminothiols and analogs thereof | Nov 16, 2016 | Issued |